Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Major initiative launched to advance the application of AI to health care

    ... the American Medical Association says is leading to a steady increase in physician burnout. AI is the most powerful technology we have today to tackle issues like this one, but there is still a ...

    sommers - 02/21/2019 - 9:51am

  2. Bowtie-funnel combo best for conducting light; team found answer in undergrad physics equation

    ... faster, lighter and more energy efficient. A version of that technology already exists in fiber optic cables, but they’re much too large ... surrounded by air to make the bowtie shape. “To increase optical energy density, there are generally two ways: focus light down ...

    sommers - 02/21/2019 - 9:51am

  3. Tech Connect, Vol. 6, Issue 7: Collaboration seeks to develop new therapies for bone and other diseases

    ... Manager of Biotech Licensing in the  Vanderbilt Center for Technology Transfer & Commercialization , facilitated the agreement with La ... epithelial cell apoptosis  9,133,212   Inhibitors of hemeprotein-catalyzed lipid peroxidation 9,127,005   ...

    steelmk - 11/15/2016 - 4:11pm

  4. Tech Connect, Vol. 7, Issue 14: Vanderbilt Cardiac Innovations

    ... acetycholine receptor M1 9,545,385    Inhibitors of hemeprotein-catalyzed lipid peroxidation 9,549,720 ... Technology Spotlight: Near-Infrared Dye with Large Stokes ...

    steelmk - 07/21/2017 - 3:15pm

  5. Tech Connect, Vol. 6, Issue 4: Vanderbilt University and La Jolla Pharmaceutical Company enter Exclusive Research and License Agreement

    ... to research and develop small-molecule BMP type-I receptor inhibitors designed to aid in treatment of rare genetic disorders. Click ... equipment supplier regarding Doppler Ultrasound Phantom technology developed by Jared Grice from the Department of Radiology ...

    steelmk - 11/15/2016 - 4:19pm

  6. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  7. FIRST Diagnostics wins 2015 Tech Venture Challenge

    ... then develop commercialization plans for the researcher's technology and present the plans before a panel of judges. Four business plans ... has uncovered new strategies for synthesizing COX-2 inhibitors and has suggested new biological roles for the enzyme, which is ...

    nbmas - 10/02/2015 - 10:43am

  8. Tech Connect, Vol. 6, Issue 22: CTTC team presents, participates at 2016 SEMDA meeting

    ... Association (SEMDA) annual meeting as part of CTTC’s technology marketing efforts. This year, twelve Vanderbilt technologies were ... 9,328,142      Lipopeptide inhibitors of RAS oncoproteins ...

    steelmk - 11/10/2016 - 7:45am

  9. Tech Connect, Vol. 6, Issue 12: nPhase closes on its first round of funding

    ... Held a call with an agriculture and animal health technology development group to discuss the insect repellent compounds created ... imaging live cells 9,212,180     Menin-MLL inhibitors and methods of use thereof ...

    steelmk - 11/15/2016 - 2:58pm

  10. New Drug for Blood Clot: FXII Inhibitors to Treat Thrombosis

    ... based on new molecular entities. Description of Technology Activation of the contact pathway (FXI, FXII, Prekallikrein, ... with fast on and low off rate. There are currently no FXII inhibitors on the therapeutic anticoagulant market. Existing anticoagulants on ...

    cttc_admin - 05/31/2023 - 2:06pm